Complement regulatory protein Crry deficiency contributes to the antigen specific recall response in experimental autoimmune myasthenia gravis
<p>Abstract</p> <p>Background</p> <p>Myasthenia gravis (MG) and animal model of experimental autoimmune myasthenia gravis (EAMG) is the most common autoimmune disorder of neuromuscular transmission. The disease is caused by the breakdown of the acetylcholine receptor (A...
Main Authors: | Soltys Jindrich, Wu Xiaobo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-05-01
|
Series: | Journal of Inflammation |
Subjects: | |
Online Access: | http://www.journal-inflammation.com/content/9/1/20 |
Similar Items
-
New Approaches to Targeting B Cells for Myasthenia Gravis Therapy
by: Ruksana Huda
Published: (2020-02-01) -
Myasthenia gravis and acetylcholine receptor antibodies: A clinico immunological correlative study on South Indian patients
by: Bindu P, et al.
Published: (2008-01-01) -
Treatment of Autoimmune Myasthenia Gravis
by: J Gordon Millichap
Published: (2004-02-01) -
Immunopathology of Autoimmune Myasthenia Gravis: Implications for Improved Testing Algorithms and Treatment Strategies
by: Hans Frykman, et al.
Published: (2020-12-01) -
Έκφραση, απομόνωση και χαρακτηρισμός της εξωκυτταρικής περιοχής της α1 υπομονάδας του ανθρώπινου νικοτινικού υποδοχέα της ακετυλοχολίνης
by: Γεωργοστάθη, Ασημίνα
Published: (2010)